Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil for postoperative analgesia after VATS lobectomy
ChiCTR2600132168Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of tegileridine and sufentanil in acute postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: AUC of NRS at rest within 24 hours after surgery. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
tegileridinesufentanil
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2600132168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132168.